CD96+ NK cells were notably increased in HCC tumor tissue and linked to poor clinical outcomes, while the blockage of TGF-β1 or CD96-CD155 interaction can rescue the NK cell dysfunction and proposed possible routes for PLC therapy [100]. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.